Toronto, Ontario--(November 1, 2021) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the "Company" or "Datametrex") is pleased to announce that its wholly-owned subsidiary Medi-Call MD Inc, ("Medi-Call") is officially launching expanded Medi-Call services to include in-person visits at a residential or work setting in Greater Vancouver Area (GVA).
The Company has been working with the development team to create an ecosystem where certified physicians can not only examine patients via its mobile app but also can be dispatched to patients' residences or places of work to provide medical services in person. Patients would be able to make the appointment through the Medi-Call app and go on with their daily business until the physician arrives. Patients can track the progress of the doctor and wait for their expected visit in real-time on the Medi-Call app with its alert system.
"We are excited to announce the addition of a crucial service for Medi-Call subscribers. A physical visit by a physician has been proven optimal for efficacious diagnostic and treatment results, as not all primary care level visits can be dealt with safely and efficiently via video or telehealth. In-person Medi-Call visits in addition to e-health improve the patients' experience by increasing access to care and healthcare delivery at large," stated Dr. Omar Sharif, President of Medi-Call and Chief Medical Officer of Datamertrex.
"Medi-Call is committed to preserving ongoing continuity of care and the highest clinical standards. Patients will have the option of requesting their favourite providers, but if time is of critical importance on a given day, the nearest provider even if different, will have full access to all their medical history through the safe and secure electronic medical record-keeping system. Regardless of visit location even if it is in a different city. So, in essence, a patient's doctor's office will for the first time, travel with the client throughout Canada," said Marshall Gunter, CEO of the Company.
About Medi-Call MD Inc.
Medi-Call is an enhanced telemedicine company providing technology-driven e-health or m-health care services including prescriptions, launching initially in British Columbia, and then expanding across Canada. The objectives of Medi-Call, include making health care accessible to people who live in rural or isolated communities and making services more readily available or convenient for people with limited time, mobility, or transportation choices. Medi-Call is driven to improve coordination and communication of treatment among members of a health care team and its patients.
Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex's mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain.
For additional information on Datametrex and other corporate information, please visit the Company's website at www.datametrex.com.
For further information, please contact: Marshall Gunter - CEO Phone: (514) 295-2300 Email: email@example.com
Neither the TSX Venture Exchange nor it's Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
All statements included in this press release that address activities, events, or developments that the Company expects, believes, or anticipates will or may occur in the future are forward-looking statements. These forward-looking statements involve numerous assumptions made by the Company based on its experience, perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. In addition, these statements involve substantial known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections, and other forward-looking statements will prove inaccurate, certain of which are beyond the Company's control. In particular, there is no guarantee that the parties will successfully negotiate and enter into a definitive agreement on mutually acceptable terms or complete the Transaction in the manner contemplated herein, if at all, that the due diligence of any of the parties will be satisfactory, or that the parties will obtain any required board, shareholder, third-party and/or regulatory or other governmental approvals, if any. Readers should not place undue reliance on forward-looking statements. Except as required by law, the Company does not undertake to revise or update these forward-looking statements after the date hereof or revise them to reflect the occurrence of future unanticipated events.